Abstract
Background/Aim: Few previous studies have evaluated the effectiveness of single-isocenter multitarget (SIMT) stereotactic radiosurgery (SRS) in clinical practice. Patients and Methods: Gross tumor volumes of 113 metastases in 13 patients were measured by contrastenhanced magnetic resonance imaging. Prescribed doses were set at 20-24 Gy. Based on tumor reduction rates (TRRs) measured before and after SIMT SRS, tumor shrinkage effect was categorized into four grades; almost disappeared: TRR=1, decreased: 0.3≤TRR<1, stable:-0.2 <3.2 cm, middle group with a distance of ≥3.2 cm and <6.4 cm, and far group with a distance of ≥6.4 cm, categorized by distance from the isocenter. Results: Median survival time was 17 months, with 63.7%, 11.5% and 12.4% of metastases corresponded to almost disappeared, decreased and stable, respectively. No significant difference was found in the distribution for TRRs among 3 groups. Conclusion: Good local control of multiple brain metastases was demonstrated by SIMT SRS, irrespective of distance from the isocenter.
Author supplied keywords
Cite
CITATION STYLE
Aoki, K., Nagatani, Y., Noma, K., Tsugawa, T., Kono, N., Kida, Y., … Watanabe, Y. (2021). Effective control of brain metastases irrespective of distance from isocenter in single-isocenter multitarget stereotactic radiosurgery. Anticancer Research, 41(5), 2575–2581. https://doi.org/10.21873/ANTICANRES.15036
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.